Organoids Market Size, Growth, Share by 2031
The organoids market size is projected to reach US$ 15.01 billion by 2031 from US$ 3.03 billion in 2023. The market is expected to register a CAGR of 22.3% in 2023–2031. The integration of artificial intelligence is likely to act as one of the key trends in the organoids market in the future.
Organoids Market Analysis
Factors contributing to the organoids market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.
Organoids Market Overview
Organoids are emerging as a powerful asset for researchers and drug developers as they seek more efficient and accurate methods to identify promising drug candidates and predict their efficacy. The ability to generate patient-derived organoids (PDOs) opens up exciting possibilities for personalized drug screening. Organoids serve as realistic and relevant models for drug screening compared to traditional 2D cell cultures. They mimic the complexity of human organs, including their cellular composition, structure, and function, providing a more accurate representation of drug responses in the human body. This enables researchers to identify potential drug candidates more confidently, and avoid costly and time-consuming setbacks in clinical trials. The organoid market is experiencing rapid growth owing to the increasing demand for innovative screening services.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Organoids Market: Strategic Insights
Market Size Value in US$ 2,507.28 million in 2022 Market Size Value by US$ 12,206.15 million by 2030 Growth rate CAGR 21.9% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Organoids Market: Strategic Insights
| Market Size Value in | US$ 2,507.28 million in 2022 |
| Market Size Value by | US$ 12,206.15 million by 2030 |
| Growth rate | CAGR 21.9% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Organoids Market Drivers and Opportunities
Surge in Popularity of Personalized Drugs Favors Organoids Market
Personalized or precision medicine is the study of practices or drugs tailored to the individual patient based on the projected response or disease risk. According to a study released by the Personalized Medicine Coalition (PMC), the share of personalized medication approvals in total FDA approvals for new molecular entities rose from 5% in 2005 to over 25% in 2016. Further, 73% of compounds in the pipeline are potential oncological candidates, and 42% have the potential to be personalized therapies. Biopharmaceutical companies have virtually doubled their R&D investments in personalized pharmaceuticals. Further, in the coming years, this spending is expected to surge by 33%. Moreover, researchers in the field of biopharmaceuticals anticipate a 69% rise in the creation of customized medications during the said period. As per the most recent study published in the PMC in 2021, the number of customized medications available in the US market has jumped up from 132 in 2016 to 286 in 2020. The information was produced by tracking the PMC's numbers for personalized medication since 2008. The use of organoids to produce customized medication regimens holds significant prospects for enhancing patient care. With their active efforts to promote and raise awareness of precision medicine, pharmacists play a crucial role in driving up demand for customized medications. According to a recent published in one of the NCBI journals in 2021, more than 50% of consumers preferred to buy customized goods or services. These stats indicate the build up of a conducive environment for the growth of the organoids market.
Key Developments by Companies to Create Opportunities for Organoids Market Growth
The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:
- In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products when needed.
- In January 2024, HUB Organoids (HUB) launched IntegriGut Screen services for the global market. This screening service employs IBD PDO monolayers to aid in the development of novel IBD therapies by ensuring the availability of high-quality human data on epithelial barrier function.
- In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.
- In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.
- In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.
Such key developments, launches, and strategic collaborations create ample opportunities for the organoid market growth.
Organoids Market Report Segmentation Analysis
Key segments that contributed to the derivation of the organoids market analysis are product, application, source, and manufacturing.
- Based on type, the organoids market is classified into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the market in 2023, and it is further anticipated to register the highest CAGR during the forecast period.
- By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031.
- Based on source, the organoids market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.
- The organoids market, by offerings, is segregated into instruments, consumables, and services. Instruments segment is further divided into devices and equipment. On the other hand, consumables segment is divided into sensors and others. The consumables segment held the largest share in the organoids market in 2023.
- The organoids market, by method, is segregated into hanging drop, micropatterned plates, ultralow attachment plates, microdroplet/emulsion, and others. The hanging drop segment held the largest share in the organoids market in 2023.
Organoids Market Share Analysis by Geography
The geographic scope of the organoids market report is mainly divided into five regions: North America, Asia Pacific, Europe, and the Middle East & Africa.
North America dominates the organoids market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023–2031.
Organoids Market Report Scope
Organoids Market News and Recent Developments
The organoids market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
- InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research. (InSphero, Press Release, May 2024)
Organoids Market Report Coverage and Deliverables
The "Organoids Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Organoids market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Organoids market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter's Five Forces and SWOT analysis
- Organoids market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Organoids market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Organ Type, Application, Source, Type, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The increasing demand for innovative drug screening services, a rise in the prevalence of skin disorders, and a surge in the popularity of personalized drugs are the key factors driving the market.
The market is expected to register a CAGR of 22.3% during 2023–2031.
North America dominated the market in 2023.
Strategic initiatives by companies would bring attractive trends in the market in the coming years.
The estimated value of the market would be US$ 15.01 billion by 2031.
Sino Biological Inc.; Eurofins Scientific SE; Molecular Devices, LLC.; InSphero; Cyprio; InnoSer; LABTOO; CUSABIO TECHNOLOGY LLC; Oncodesign Services; and HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key players in the market.
1. Introduction 39
1.1 The Insight Partners Research Report Guidance. 39
1.2 Market Segmentation. 40
2. Executive Summary 41
2.1 Key Insights. 41
3. Research Methodology 42
3.1 Secondary Research. 43
3.2 Primary Research. 43
3.2.1 Hypothesis formulation: 43
3.2.2 Macro-economic factor analysis: 44
3.2.3 Developing base number: 44
3.2.4 Data Triangulation: 44
3.2.5 Country level data: 44
4. Organoids Market Landscape 45
4.1 PEST Analysis. 45
5. Organoids Market – Key Market Dynamics 46
5.1 Organoids Market – Key Market Dynamics. 46
5.2 Market Drivers. 46
5.2.1 Increasing Demand for Tumor Modeling and Biobanking. 46
5.2.2 Surging Adoption of Personalized Drugs. 47
5.3 Market Restraints. 48
5.3.1 Dearth of Skilled Professionals. 48
5.4 Market Opportunities. 48
5.4.1 Focus on Drug Discovery Activities. 48
5.5 Future Trends. 49
5.5.1 Combination of Organoids and Organ-on-a-Chip. 49
5.6 Impact of Drivers and Restraints: 49
6. Organoids Market – Global Market Analysis 50
6.1 Organoids Market Revenue (US$ Million), 2021–2031. 50
6.2 Organoids Market Forecast Analysis. 51
7. Organoids Market Analysis – by Type 52
7.1 Intestine. 53
7.1.1 Overview. 53
7.1.2 Intestine: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 53
7.2 Liver 54
7.2.1 Overview. 54
7.2.2 Liver: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 54
7.3 Stomach. 55
7.3.1 Overview. 55
7.3.2 Stomach: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 55
7.4 Pancreas. 56
7.4.1 Overview. 56
7.4.2 Pancreas: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 56
7.5 Lung. 57
7.5.1 Overview. 57
7.5.2 Lung: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 57
7.6 Brain. 58
7.6.1 Overview. 58
7.6.2 Brain: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 58
7.7 Kidney. 59
7.7.1 Overview. 59
7.7.2 Kidney: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 59
7.8 Others. 60
7.8.1 Overview. 60
7.8.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 60
8. Organoids Market Analysis – by Application 61
8.1 Developmental Biology Disease. 62
8.1.1 Overview. 62
8.1.2 Developmental Biology Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 62
8.2 Pathology of Infectious Disease. 63
8.2.1 Overview. 63
8.2.2 Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 63
8.3 Regenerative Medicine. 64
8.3.1 Overview. 64
8.3.2 Regenerative Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 64
8.4 Drug Toxicity and Efficacy Testing. 65
8.4.1 Overview. 65
8.4.2 Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 65
8.5 Drug Discovery and Personalized Medicine. 66
8.5.1 Overview. 66
8.5.2 Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 66
8.6 Others. 67
8.6.1 Overview. 67
8.6.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 67
9. Organoids Market Analysis – by Source 68
9.1 Pluripotent Stem Cells. 69
9.1.1 Overview. 69
9.1.2 Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 69
9.2 Organ-Specific Adult Stem Cell 70
9.2.1 Overview. 70
9.2.2 Organ-Specific Adult Stem Cell: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 70
10. Organoids Market Analysis – by Offering 71
10.1 Instruments. 72
10.1.1 Overview. 72
10.1.2 Instruments: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 72
10.2 Consumables. 73
10.2.1 Overview. 73
10.2.2 Consumables: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 73
10.3 Services. 74
10.3.1 Overview. 74
10.3.2 Services: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 74
11. Organoids Market Analysis – by Method 75
11.1 Micropatterned Plates. 76
11.1.1 Overview. 76
11.1.2 Micropatterned Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 76
11.2 Ultralow Attachment Plates. 77
11.2.1 Overview. 77
11.2.2 Ultralow Attachment Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 77
11.3 Hanging Drop. 78
11.3.1 Overview. 78
11.3.2 Hanging Drop: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 78
11.4 Microdroplet or Emulsion. 79
11.4.1 Overview. 79
11.4.2 Microdroplet or Emulsion: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 79
11.5 Others. 80
11.5.1 Overview. 80
11.5.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 80
12. Organoids Market – Geographical Analysis 81
12.1 Overview. 81
12.2 North America. 82
12.2.1 North America Organoids Market Overview. 82
12.2.2 North America: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 82
12.2.3 North America: Organoids Market Breakdown, by Type. 83
12.2.3.1 North America: Organoids Market – Revenue and Forecast Analysis – by Type. 83
12.2.4 North America: Organoids Market Breakdown, by Application. 84
12.2.4.1 North America: Organoids Market – Revenue and Forecast Analysis – by Application. 84
12.2.5 North America: Organoids Market Breakdown, by Source. 85
12.2.5.1 North America: Organoids Market – Revenue and Forecast Analysis – by Source. 85
12.2.6 North America: Organoids Market Breakdown, by Offering. 86
12.2.6.1 North America: Organoids Market – Revenue and Forecast Analysis – by Offering. 86
12.2.7 North America: Organoids Market Breakdown, by Instruments. 87
12.2.7.1 North America: Organoids Market – Revenue and Forecast Analysis – by Instruments. 87
12.2.8 North America: Organoids Market Breakdown, by Consumables. 88
12.2.8.1 North America: Organoids Market – Revenue and Forecast Analysis – by Consumables. 88
12.2.9 North America: Organoids Market Breakdown, by Method. 89
12.2.9.1 North America: Organoids Market – Revenue and Forecast Analysis – by Method. 89
12.2.10 North America: Organoids Market – Revenue and Forecast Analysis – by Country. 90
12.2.10.1 North America: Organoids Market – Revenue and Forecast Analysis – by Country. 90
12.2.10.2 United States: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 91
12.2.10.2.1 United States: Organoids Market Breakdown, by Type. 92
12.2.10.2.2 United States: Organoids Market Breakdown, by Application. 92
12.2.10.2.3 United States: Organoids Market Breakdown, by Source. 93
12.2.10.2.4 United States: Organoids Market Breakdown, by Offering. 93
12.2.10.2.5 United States: Organoids Market Breakdown, by Instruments. 93
12.2.10.2.6 United States: Organoids Market Breakdown, by Consumables. 94
12.2.10.2.7 United States: Organoids Market Breakdown, by Method. 94
12.2.10.3 Canada: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 95
12.2.10.3.1 Canada: Organoids Market Breakdown, by Type. 96
12.2.10.3.2 Canada: Organoids Market Breakdown, by Application. 96
12.2.10.3.3 Canada: Organoids Market Breakdown, by Source. 97
12.2.10.3.4 Canada: Organoids Market Breakdown, by Offering. 97
12.2.10.3.5 Canada: Organoids Market Breakdown, by Instruments. 97
12.2.10.3.6 Canada: Organoids Market Breakdown, by Consumables. 98
12.2.10.3.7 Canada: Organoids Market Breakdown, by Method. 98
12.2.10.4 Mexico: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 99
12.2.10.4.1 Mexico: Organoids Market Breakdown, by Type. 100
12.2.10.4.2 Mexico: Organoids Market Breakdown, by Application. 100
12.2.10.4.3 Mexico: Organoids Market Breakdown, by Source. 101
12.2.10.4.4 Mexico: Organoids Market Breakdown, by Offering. 101
12.2.10.4.5 Mexico: Organoids Market Breakdown, by Instruments. 101
12.2.10.4.6 Mexico: Organoids Market Breakdown, by Consumables. 102
12.2.10.4.7 Mexico: Organoids Market Breakdown, by Method. 102
12.3 Europe. 103
12.3.1 Europe Organoids Market Overview. 103
12.3.2 Europe: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 103
12.3.3 Europe: Organoids Market Breakdown, by Type. 104
12.3.3.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Type. 104
12.3.4 Europe: Organoids Market Breakdown, by Application. 105
12.3.4.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Application. 105
12.3.5 Europe: Organoids Market Breakdown, by Source. 106
12.3.5.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Source. 106
12.3.6 Europe: Organoids Market Breakdown, by Offering. 107
12.3.6.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Offering. 107
12.3.7 Europe: Organoids Market Breakdown, by Instruments. 108
12.3.7.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Instruments. 108
12.3.8 Europe: Organoids Market Breakdown, by Consumables. 109
12.3.8.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Consumables. 109
12.3.9 Europe: Organoids Market Breakdown, by Method. 110
12.3.9.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Method. 110
12.3.10 Europe: Organoids Market – Revenue and Forecast Analysis – by Country. 111
12.3.10.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Country. 111
12.3.10.2 Germany: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 112
12.3.10.2.1 Germany: Organoids Market Breakdown, by Type. 113
12.3.10.2.2 Germany: Organoids Market Breakdown, by Application. 113
12.3.10.2.3 Germany: Organoids Market Breakdown, by Source. 114
12.3.10.2.4 Germany: Organoids Market Breakdown, by Offering. 114
12.3.10.2.5 Germany: Organoids Market Breakdown, by Instruments. 114
12.3.10.2.6 Germany: Organoids Market Breakdown, by Consumables. 115
12.3.10.2.7 Germany: Organoids Market Breakdown, by Method. 115
12.3.10.3 France: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 116
12.3.10.3.1 France: Organoids Market Breakdown, by Type. 117
12.3.10.3.2 France: Organoids Market Breakdown, by Application. 117
12.3.10.3.3 France: Organoids Market Breakdown, by Source. 118
12.3.10.3.4 France: Organoids Market Breakdown, by Offering. 118
12.3.10.3.5 France: Organoids Market Breakdown, by Instruments. 118
12.3.10.3.6 France: Organoids Market Breakdown, by Consumables. 119
12.3.10.3.7 France: Organoids Market Breakdown, by Method. 119
12.3.10.4 United Kingdom: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 120
12.3.10.4.1 United Kingdom: Organoids Market Breakdown, by Type. 121
12.3.10.4.2 United Kingdom: Organoids Market Breakdown, by Application. 121
12.3.10.4.3 United Kingdom: Organoids Market Breakdown, by Source. 122
12.3.10.4.4 United Kingdom: Organoids Market Breakdown, by Offering. 122
12.3.10.4.5 United Kingdom: Organoids Market Breakdown, by Instruments. 122
12.3.10.4.6 United Kingdom: Organoids Market Breakdown, by Consumables. 123
12.3.10.4.7 United Kingdom: Organoids Market Breakdown, by Method. 123
12.3.10.5 Italy: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 124
12.3.10.5.1 Italy: Organoids Market Breakdown, by Type. 125
12.3.10.5.2 Italy: Organoids Market Breakdown, by Application. 125
12.3.10.5.3 Italy: Organoids Market Breakdown, by Source. 126
12.3.10.5.4 Italy: Organoids Market Breakdown, by Offering. 126
12.3.10.5.5 Italy: Organoids Market Breakdown, by Instruments. 126
12.3.10.5.6 Italy: Organoids Market Breakdown, by Consumables. 127
12.3.10.5.7 Italy: Organoids Market Breakdown, by Method. 127
12.3.10.6 Spain: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 128
12.3.10.6.1 Spain: Organoids Market Breakdown, by Type. 129
12.3.10.6.2 Spain: Organoids Market Breakdown, by Application. 129
12.3.10.6.3 Spain: Organoids Market Breakdown, by Source. 130
12.3.10.6.4 Spain: Organoids Market Breakdown, by Offering. 130
12.3.10.6.5 Spain: Organoids Market Breakdown, by Instruments. 130
12.3.10.6.6 Spain: Organoids Market Breakdown, by Consumables. 131
12.3.10.6.7 Spain: Organoids Market Breakdown, by Method. 131
12.3.10.7 Rest of Europe: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 132
12.3.10.7.1 Rest of Europe: Organoids Market Breakdown, by Type. 133
12.3.10.7.2 Rest of Europe: Organoids Market Breakdown, by Application. 133
12.3.10.7.3 Rest of Europe: Organoids Market Breakdown, by Source. 134
12.3.10.7.4 Rest of Europe: Organoids Market Breakdown, by Offering. 134
12.3.10.7.5 Rest of Europe: Organoids Market Breakdown, by Instruments. 134
12.3.10.7.6 Rest of Europe: Organoids Market Breakdown, by Consumables. 135
12.3.10.7.7 Rest of Europe: Organoids Market Breakdown, by Method. 135
12.4 Asia Pacific. 136
12.4.1 Asia Pacific Organoids Market Overview. 136
12.4.2 Asia Pacific: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 136
12.4.3 Asia Pacific: Organoids Market Breakdown, by Type. 137
12.4.3.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Type. 137
12.4.4 Asia Pacific: Organoids Market Breakdown, by Application. 138
12.4.4.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Application. 138
12.4.5 Asia Pacific: Organoids Market Breakdown, by Source. 139
12.4.5.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Source. 139
12.4.6 Asia Pacific: Organoids Market Breakdown, by Offering. 140
12.4.6.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Offering. 140
12.4.7 Asia Pacific: Organoids Market Breakdown, by Instruments. 141
12.4.7.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Instruments. 141
12.4.8 Asia Pacific: Organoids Market Breakdown, by Consumables. 142
12.4.8.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Consumables. 142
12.4.9 Asia Pacific: Organoids Market Breakdown, by Method. 143
12.4.9.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Method. 143
12.4.10 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Country. 144
12.4.10.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Country. 144
12.4.10.2 Japan: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 145
12.4.10.2.1 Japan: Organoids Market Breakdown, by Type. 146
12.4.10.2.2 Japan: Organoids Market Breakdown, by Application. 146
12.4.10.2.3 Japan: Organoids Market Breakdown, by Source. 147
12.4.10.2.4 Japan: Organoids Market Breakdown, by Offering. 147
12.4.10.2.5 Japan: Organoids Market Breakdown, by Instruments. 147
12.4.10.2.6 Japan: Organoids Market Breakdown, by Consumables. 148
12.4.10.2.7 Japan: Organoids Market Breakdown, by Method. 148
12.4.10.3 China: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 149
12.4.10.3.1 China: Organoids Market Breakdown, by Type. 150
12.4.10.3.2 China: Organoids Market Breakdown, by Application. 150
12.4.10.3.3 China: Organoids Market Breakdown, by Source. 151
12.4.10.3.4 China: Organoids Market Breakdown, by Offering. 151
12.4.10.3.5 China: Organoids Market Breakdown, by Instruments. 151
12.4.10.3.6 China: Organoids Market Breakdown, by Consumables. 152
12.4.10.3.7 China: Organoids Market Breakdown, by Method. 152
12.4.10.4 India: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 153
12.4.10.4.1 India: Organoids Market Breakdown, by Type. 154
12.4.10.4.2 India: Organoids Market Breakdown, by Application. 154
12.4.10.4.3 India: Organoids Market Breakdown, by Source. 155
12.4.10.4.4 India: Organoids Market Breakdown, by Offering. 155
12.4.10.4.5 India: Organoids Market Breakdown, by Instruments. 155
12.4.10.4.6 India: Organoids Market Breakdown, by Consumables. 156
12.4.10.4.7 India: Organoids Market Breakdown, by Method. 156
12.4.10.5 South Korea: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 157
12.4.10.5.1 South Korea: Organoids Market Breakdown, by Type. 158
12.4.10.5.2 South Korea: Organoids Market Breakdown, by Application. 158
12.4.10.5.3 South Korea: Organoids Market Breakdown, by Source. 159
12.4.10.5.4 South Korea: Organoids Market Breakdown, by Offering. 159
12.4.10.5.5 South Korea: Organoids Market Breakdown, by Instruments. 159
12.4.10.5.6 South Korea: Organoids Market Breakdown, by Consumables. 160
12.4.10.5.7 South Korea: Organoids Market Breakdown, by Method. 160
12.4.10.6 Australia: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 161
12.4.10.6.1 Australia: Organoids Market Breakdown, by Type. 162
12.4.10.6.2 Australia: Organoids Market Breakdown, by Application. 162
12.4.10.6.3 Australia: Organoids Market Breakdown, by Source. 163
12.4.10.6.4 Australia: Organoids Market Breakdown, by Offering. 163
12.4.10.6.5 Australia: Organoids Market Breakdown, by Instruments. 163
12.4.10.6.6 Australia: Organoids Market Breakdown, by Consumables. 164
12.4.10.6.7 Australia: Organoids Market Breakdown, by Method. 164
12.4.10.7 Singapore: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 165
12.4.10.7.1 Singapore: Organoids Market Breakdown, by Type. 166
12.4.10.7.2 Singapore: Organoids Market Breakdown, by Application. 166
12.4.10.7.3 Singapore: Organoids Market Breakdown, by Source. 167
12.4.10.7.4 Singapore: Organoids Market Breakdown, by Offering. 167
12.4.10.7.5 Singapore: Organoids Market Breakdown, by Instruments. 167
12.4.10.7.6 Singapore: Organoids Market Breakdown, by Consumables. 168
12.4.10.7.7 Singapore: Organoids Market Breakdown, by Method. 168
12.4.10.8 Thailand: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 169
12.4.10.8.1 Thailand: Organoids Market Breakdown, by Type. 170
12.4.10.8.2 Thailand: Organoids Market Breakdown, by Application. 170
12.4.10.8.3 Thailand: Organoids Market Breakdown, by Source. 171
12.4.10.8.4 Thailand: Organoids Market Breakdown, by Offering. 171
12.4.10.8.5 Thailand: Organoids Market Breakdown, by Instruments. 171
12.4.10.8.6 Thailand: Organoids Market Breakdown, by Consumables. 172
12.4.10.8.7 Thailand: Organoids Market Breakdown, by Method. 172
12.4.10.9 Malaysia: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 173
12.4.10.9.1 Malaysia: Organoids Market Breakdown, by Type. 174
12.4.10.9.2 Malaysia: Organoids Market Breakdown, by Application. 174
12.4.10.9.3 Malaysia: Organoids Market Breakdown, by Source. 175
12.4.10.9.4 Malaysia: Organoids Market Breakdown, by Offering. 175
12.4.10.9.5 Malaysia: Organoids Market Breakdown, by Instruments. 175
12.4.10.9.6 Malaysia: Organoids Market Breakdown, by Consumables. 176
12.4.10.9.7 Malaysia: Organoids Market Breakdown, by Method. 176
12.4.10.10 Vietnam: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 177
12.4.10.10.1 Vietnam: Organoids Market Breakdown, by Type. 178
12.4.10.10.2 Vietnam: Organoids Market Breakdown, by Application. 178
12.4.10.10.3 Vietnam: Organoids Market Breakdown, by Source. 179
12.4.10.10.4 Vietnam: Organoids Market Breakdown, by Offering. 179
12.4.10.10.5 Vietnam: Organoids Market Breakdown, by Instruments. 179
12.4.10.10.6 Vietnam: Organoids Market Breakdown, by Consumables. 180
12.4.10.10.7 Vietnam: Organoids Market Breakdown, by Method. 180
12.4.10.11 Indonesia: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 181
12.4.10.11.1 Indonesia: Organoids Market Breakdown, by Type. 182
12.4.10.11.2 Indonesia: Organoids Market Breakdown, by Application. 182
12.4.10.11.3 Indonesia: Organoids Market Breakdown, by Source. 183
12.4.10.11.4 Indonesia: Organoids Market Breakdown, by Offering. 183
12.4.10.11.5 Indonesia: Organoids Market Breakdown, by Instruments. 183
12.4.10.11.6 Indonesia: Organoids Market Breakdown, by Consumables. 184
12.4.10.11.7 Indonesia: Organoids Market Breakdown, by Method. 184
12.4.10.12 Philippines: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 185
12.4.10.12.1 Philippines: Organoids Market Breakdown, by Type. 186
12.4.10.12.2 Philippines: Organoids Market Breakdown, by Application. 186
12.4.10.12.3 Philippines: Organoids Market Breakdown, by Source. 187
12.4.10.12.4 Philippines: Organoids Market Breakdown, by Offering. 187
12.4.10.12.5 Philippines: Organoids Market Breakdown, by Instruments. 187
12.4.10.12.6 Philippines: Organoids Market Breakdown, by Consumables. 188
12.4.10.12.7 Philippines: Organoids Market Breakdown, by Method. 188
12.4.10.13 Rest of APAC: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 189
12.4.10.13.1 Rest of APAC: Organoids Market Breakdown, by Type. 190
12.4.10.13.2 Rest of APAC: Organoids Market Breakdown, by Application. 190
12.4.10.13.3 Rest of APAC: Organoids Market Breakdown, by Source. 191
12.4.10.13.4 Rest of APAC: Organoids Market Breakdown, by Offering. 191
12.4.10.13.5 Rest of APAC: Organoids Market Breakdown, by Instruments. 191
12.4.10.13.6 Rest of APAC: Organoids Market Breakdown, by Consumables. 192
12.4.10.13.7 Rest of APAC: Organoids Market Breakdown, by Method. 192
12.5 Middle East and Africa. 193
12.5.1 Middle East and Africa Organoids Market Overview. 193
12.5.2 Middle East and Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 193
12.5.3 Middle East and Africa: Organoids Market Breakdown, by Type. 194
12.5.3.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Type. 194
12.5.4 Middle East and Africa: Organoids Market Breakdown, by Application. 195
12.5.4.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Application. 195
12.5.5 Middle East and Africa: Organoids Market Breakdown, by Source. 196
12.5.5.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Source. 196
12.5.6 Middle East and Africa: Organoids Market Breakdown, by Offering. 197
12.5.6.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Offering. 197
12.5.7 Middle East and Africa: Organoids Market Breakdown, by Instruments. 198
12.5.7.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Instruments. 198
12.5.8 Middle East and Africa: Organoids Market Breakdown, by Consumables. 199
12.5.8.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Consumables. 199
12.5.9 Middle East and Africa: Organoids Market Breakdown, by Method. 200
12.5.9.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Method. 200
12.5.10 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Country. 201
12.5.10.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Country. 201
12.5.10.2 Saudi Arabia: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 202
12.5.10.2.1 Saudi Arabia: Organoids Market Breakdown, by Type. 203
12.5.10.2.2 Saudi Arabia: Organoids Market Breakdown, by Application. 203
12.5.10.2.3 Saudi Arabia: Organoids Market Breakdown, by Source. 204
12.5.10.2.4 Saudi Arabia: Organoids Market Breakdown, by Offering. 204
12.5.10.2.5 Saudi Arabia: Organoids Market Breakdown, by Instruments. 204
12.5.10.2.6 Saudi Arabia: Organoids Market Breakdown, by Consumables. 205
12.5.10.2.7 Saudi Arabia: Organoids Market Breakdown, by Method. 205
12.5.10.3 South Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 206
12.5.10.3.1 South Africa: Organoids Market Breakdown, by Type. 207
12.5.10.3.2 South Africa: Organoids Market Breakdown, by Application. 207
12.5.10.3.3 South Africa: Organoids Market Breakdown, by Source. 208
12.5.10.3.4 South Africa: Organoids Market Breakdown, by Offering. 208
12.5.10.3.5 South Africa: Organoids Market Breakdown, by Instruments. 208
12.5.10.3.6 South Africa: Organoids Market Breakdown, by Consumables. 209
12.5.10.3.7 South Africa: Organoids Market Breakdown, by Method. 209
12.5.10.4 United Arab Emirates: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 210
12.5.10.4.1 United Arab Emirates: Organoids Market Breakdown, by Type. 211
12.5.10.4.2 United Arab Emirates: Organoids Market Breakdown, by Application. 211
12.5.10.4.3 United Arab Emirates: Organoids Market Breakdown, by Source. 212
12.5.10.4.4 United Arab Emirates: Organoids Market Breakdown, by Offering. 212
12.5.10.4.5 United Arab Emirates: Organoids Market Breakdown, by Instruments. 212
12.5.10.4.6 United Arab Emirates: Organoids Market Breakdown, by Consumables. 213
12.5.10.4.7 United Arab Emirates: Organoids Market Breakdown, by Method. 213
12.5.10.5 Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 214
12.5.10.5.1 Rest of Middle East and Africa: Organoids Market Breakdown, by Type. 215
12.5.10.5.2 Rest of Middle East and Africa: Organoids Market Breakdown, by Application. 215
12.5.10.5.3 Rest of Middle East and Africa: Organoids Market Breakdown, by Source. 216
12.5.10.5.4 Rest of Middle East and Africa: Organoids Market Breakdown, by Offering. 216
12.5.10.5.5 Rest of Middle East and Africa: Organoids Market Breakdown, by Instruments. 216
12.5.10.5.6 Rest of Middle East and Africa: Organoids Market Breakdown, by Consumables. 217
12.5.10.5.7 Rest of Middle East and Africa: Organoids Market Breakdown, by Method. 217
12.6 South and Central America. 218
12.6.1 South and Central America Organoids Market Overview. 218
12.6.2 South and Central America: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 218
12.6.3 South and Central America: Organoids Market Breakdown, by Type. 219
12.6.3.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Type. 219
12.6.4 South and Central America: Organoids Market Breakdown, by Application. 220
12.6.4.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Application. 220
12.6.5 South and Central America: Organoids Market Breakdown, by Source. 221
12.6.5.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Source. 221
12.6.6 South and Central America: Organoids Market Breakdown, by Offering. 222
12.6.6.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Offering. 222
12.6.7 South and Central America: Organoids Market Breakdown, by Instruments. 223
12.6.7.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Instruments. 223
12.6.8 South and Central America: Organoids Market Breakdown, by Consumables. 224
12.6.8.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Consumables. 224
12.6.9 South and Central America: Organoids Market Breakdown, by Method. 225
12.6.9.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Method. 225
12.6.10 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Country. 226
12.6.10.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Country. 226
12.6.10.2 Brazil: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 227
12.6.10.2.1 Brazil: Organoids Market Breakdown, by Type. 228
12.6.10.2.2 Brazil: Organoids Market Breakdown, by Application. 228
12.6.10.2.3 Brazil: Organoids Market Breakdown, by Source. 229
12.6.10.2.4 Brazil: Organoids Market Breakdown, by Offering. 229
12.6.10.2.5 Brazil: Organoids Market Breakdown, by Instruments. 229
12.6.10.2.6 Brazil: Organoids Market Breakdown, by Consumables. 230
12.6.10.2.7 Brazil: Organoids Market Breakdown, by Method. 230
12.6.10.3 Argentina: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 231
12.6.10.3.1 Argentina: Organoids Market Breakdown, by Type. 232
12.6.10.3.2 Argentina: Organoids Market Breakdown, by Application. 232
12.6.10.3.3 Argentina: Organoids Market Breakdown, by Source. 233
12.6.10.3.4 Argentina: Organoids Market Breakdown, by Offering. 233
12.6.10.3.5 Argentina: Organoids Market Breakdown, by Instruments. 233
12.6.10.3.6 Argentina: Organoids Market Breakdown, by Consumables. 234
12.6.10.3.7 Argentina: Organoids Market Breakdown, by Method. 234
12.6.10.4 Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 235
12.6.10.4.1 Rest of South and Central America: Organoids Market Breakdown, by Type. 236
12.6.10.4.2 Rest of South and Central America: Organoids Market Breakdown, by Application. 236
12.6.10.4.3 Rest of South and Central America: Organoids Market Breakdown, by Source. 237
12.6.10.4.4 Rest of South and Central America: Organoids Market Breakdown, by Offering. 237
12.6.10.4.5 Rest of South and Central America: Organoids Market Breakdown, by Instruments. 237
12.6.10.4.6 Rest of South and Central America: Organoids Market Breakdown, by Consumables. 238
12.6.10.4.7 Rest of South and Central America: Organoids Market Breakdown, by Method. 238
13. Industry Landscape 239
13.1 Overview. 239
13.2 Growth Strategies in Organoids Market 239
13.3 Organic Growth Strategies. 240
13.3.1 Overview. 240
13.4 Inorganic Growth Strategies. 241
13.4.1 Overview. 241
14. Company Profiles 243
14.1 STEMCELL Technologies Inc. 243
14.1.1 Key Facts. 243
14.1.2 Business Description. 243
14.1.3 Products and Services. 243
14.1.4 Financial Overview. 244
14.1.5 SWOT Analysis. 244
14.1.6 Key Developments. 244
14.2 Molecular Devices, LLC. 245
14.2.1 Key Facts. 245
14.2.2 Business Description. 245
14.2.3 Products and Services. 245
14.2.4 Financial Overview. 245
14.2.5 SWOT Analysis. 246
14.2.6 Key Developments. 247
14.3 Hubrecht Organoid Technology. 248
14.3.1 Key Facts. 248
14.3.2 Business Description. 248
14.3.3 Products and Services. 248
14.3.4 Financial Overview. 249
14.3.5 SWOT Analysis. 249
14.3.6 Key Developments. 249
14.4 Definigen. 251
14.4.1 Key Facts. 251
14.4.2 Business Description. 251
14.4.3 Products and Services. 251
14.4.4 Financial Overview. 251
14.4.5 SWOT Analysis. 252
14.4.6 Key Developments. 252
14.5 Organoid Therapeutics. 253
14.5.1 Key Facts. 253
14.5.2 Business Description. 253
14.5.3 Products and Services. 253
14.5.4 Financial Overview. 253
14.5.5 SWOT Analysis. 254
14.5.6 Key Developments. 254
14.6 Thermo Fisher Scientific Inc. 255
14.6.1 Key Facts. 255
14.6.2 Business Description. 255
14.6.3 Products and Services. 257
14.6.4 Financial Overview. 257
14.6.5 SWOT Analysis. 259
14.6.6 Key Developments. 259
14.7 Corning Inc. 260
14.7.1 Key Facts. 260
14.7.2 Business Description. 260
14.7.3 Products and Services. 261
14.7.4 Financial Overview. 261
14.7.5 SWOT Analysis. 263
14.7.6 Key Developments. 263
14.8 Merck KGaA. 264
14.8.1 Key Facts. 264
14.8.2 Business Description. 264
14.8.3 Products and Services. 265
14.8.4 Financial Overview. 265
14.8.5 SWOT Analysis. 267
14.8.6 Key Developments. 267
14.9 InSphero. 268
14.9.1 Key Facts. 268
14.9.2 Business Description. 268
14.9.3 Products and Services. 268
14.9.4 Financial Overview. 268
14.9.5 SWOT Analysis. 269
14.9.6 Key Developments. 269
14.10 ACRO Biosystems. 270
14.10.1 Key Facts. 270
14.10.2 Business Description. 270
14.10.3 Products and Services. 270
14.10.4 Financial Overview. 271
14.10.5 SWOT Analysis. 271
14.10.6 Key Developments. 272
14.11 Bio-Techne Corp. 273
14.11.1 Key Facts. 273
14.11.2 Business Description. 273
14.11.3 Products and Services. 274
14.11.4 Financial Overview. 274
14.11.5 SWOT Analysis. 276
14.11.6 Key Developments. 276
14.12 SUN bioscience SA. 277
14.12.1 Key Facts. 277
14.12.2 Business Description. 277
14.12.3 Products and Services. 277
14.12.4 Financial Overview. 277
14.12.5 SWOT Analysis. 278
14.12.6 Key Developments. 278
14.13 ORGANOID SCIENCES Co., Ltd. 279
14.13.1 Key Facts. 279
14.13.2 Business Description. 279
14.13.3 Products and Services. 279
14.13.4 Financial Overview. 279
14.13.5 SWOT Analysis. 280
14.13.6 Key Developments. 280
14.14 Crown Bioscience Inc. 281
14.14.1 Key Facts. 281
14.14.2 Business Description. 281
14.14.3 Products and Services. 281
14.14.4 Financial Overview. 281
14.14.5 SWOT Analysis. 282
14.14.6 Key Developments. 282
14.15 Sartorius AG. 283
14.15.1 Key Facts. 283
14.15.2 Business Description. 283
14.15.3 Products and Services. 284
14.15.4 Financial Overview. 284
14.15.5 SWOT Analysis. 286
14.15.6 Key Developments. 286
14.16 3D Biotek LLC. 287
14.16.1 Key Facts. 287
14.16.2 Business Description. 287
14.16.3 Products and Services. 287
14.16.4 Financial Overview. 287
14.16.5 SWOT Analysis. 288
14.16.6 Key Developments. 288
14.17 Prellis Biologics Inc. 289
14.17.1 Key Facts. 289
14.17.2 Business Description. 289
14.17.3 Products and Services. 289
14.17.4 Financial Overview. 289
14.17.5 SWOT Analysis. 290
14.17.6 Key Developments. 290
14.18 3Dnamics Inc. 291
14.18.1 Key Facts. 291
14.18.2 Business Description. 291
14.18.3 Products and Services. 291
14.18.4 Financial Overview. 291
14.18.5 SWOT Analysis. 292
14.18.6 Key Developments. 292
14.19 Cellesce Ltd. 293
14.19.1 Key Facts. 293
14.19.2 Business Description. 293
14.19.3 Products and Services. 293
14.19.4 Financial Overview. 293
14.19.5 SWOT Analysis. 294
14.19.6 Key Developments. 294
15. Appendix 295
15.1 About The Insight Partners. 295
List of Tables
Table 1. Organoids Market Segmentation. 40
Table 2. Organoids Market – Revenue and Forecast to 2031 (US$ Million) 51
Table 3. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 52
Table 4. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 61
Table 5. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Source. 68
Table 6. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Offering. 71
Table 7. Global: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 72
Table 8. Global: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 73
Table 9. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Method. 75
Table 10. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 83
Table 11. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 84
Table 12. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 85
Table 13. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 86
Table 14. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 87
Table 15. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 88
Table 16. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 89
Table 17. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country. 90
Table 18. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 92
Table 19. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 92
Table 20. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 93
Table 21. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 93
Table 22. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 93
Table 23. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 94
Table 24. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 94
Table 25. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 96
Table 26. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 96
Table 27. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 97
Table 28. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 97
Table 29. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 97
Table 30. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 98
Table 31. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 98
Table 32. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 100
Table 33. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 100
Table 34. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 101
Table 35. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 101
Table 36. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 101
Table 37. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 102
Table 38. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 102
Table 39. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 104
Table 40. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 105
Table 41. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 106
Table 42. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 107
Table 43. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 108
Table 44. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 109
Table 45. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 110
Table 46. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country. 111
Table 47. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 113
Table 48. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 113
Table 49. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 114
Table 50. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 114
Table 51. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 114
Table 52. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 115
Table 53. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 115
Table 54. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 117
Table 55. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 117
Table 56. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 118
Table 57. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 118
Table 58. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 118
Table 59. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 119
Table 60. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 119
Table 61. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 121
Table 62. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 121
Table 63. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 122
Table 64. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 122
Table 65. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 122
Table 66. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 123
Table 67. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 123
Table 68. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 125
Table 69. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 125
Table 70. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 126
Table 71. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 126
Table 72. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 126
Table 73. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 127
Table 74. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 127
Table 75. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 129
Table 76. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 129
Table 77. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 130
Table 78. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 130
Table 79. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 130
Table 80. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 131
Table 81. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 131
Table 82. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 133
Table 83. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 133
Table 84. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 134
Table 85. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 134
Table 86. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 134
Table 87. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 135
Table 88. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 135
Table 89. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 137
Table 90. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 138
Table 91. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 139
Table 92. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 140
Table 93. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 141
Table 94. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 142
Table 95. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 143
Table 96. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country. 144
Table 97. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 146
Table 98. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 146
Table 99. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 147
Table 100. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 147
Table 101. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 147
Table 102. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 148
Table 103. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 148
Table 104. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 150
Table 105. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 150
Table 106. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 151
Table 107. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 151
Table 108. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 151
Table 109. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 152
Table 110. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 152
Table 111. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 154
Table 112. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 154
Table 113. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 155
Table 114. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 155
Table 115. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 155
Table 116. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 156
Table 117. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 156
Table 118. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 158
Table 119. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 158
Table 120. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 159
Table 121. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 159
Table 122. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 159
Table 123. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 160
Table 124. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 160
Table 125. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 162
Table 126. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 162
Table 127. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 163
Table 128. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 163
Table 129. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 163
Table 130. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 164
Table 131. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 164
Table 132. Singapore: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 166
Table 133. Singapore: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 166
Table 134. Singapore: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 167
Table 135. Singapore: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 167
Table 136. Singapore: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 167
Table 137. Singapore: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 168
Table 138. Singapore: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 168
Table 139. Thailand: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 170
Table 140. Thailand: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 170
Table 141. Thailand: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 171
Table 142. Thailand: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 171
Table 143. Thailand: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 171
Table 144. Thailand: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 172
Table 145. Thailand: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 172
Table 146. Malaysia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 174
Table 147. Malaysia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 174
Table 148. Malaysia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 175
Table 149. Malaysia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 175
Table 150. Malaysia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 175
Table 151. Malaysia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 176
Table 152. Malaysia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 176
Table 153. Vietnam: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 178
Table 154. Vietnam: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 178
Table 155. Vietnam: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 179
Table 156. Vietnam: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 179
Table 157. Vietnam: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 179
Table 158. Vietnam: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 180
Table 159. Vietnam: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 180
Table 160. Indonesia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 182
Table 161. Indonesia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 182
Table 162. Indonesia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 183
Table 163. Indonesia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 183
Table 164. Indonesia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 183
Table 165. Indonesia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 184
Table 166. Indonesia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 184
Table 167. Philippines: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 186
Table 168. Philippines: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 186
Table 169. Philippines: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 187
Table 170. Philippines: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 187
Table 171. Philippines: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 187
Table 172. Philippines: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 188
Table 173. Philippines: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 188
Table 174. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 190
Table 175. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 190
Table 176. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 191
Table 177. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 191
Table 178. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 191
Table 179. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 192
Table 180. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 192
Table 181. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 194
Table 182. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 195
Table 183. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 196
Table 184. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 197
Table 185. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 198
Table 186. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 199
Table 187. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 200
Table 188. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country. 201
Table 189. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 203
Table 190. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 203
Table 191. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 204
Table 192. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 204
Table 193. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 204
Table 194. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 205
Table 195. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 205
Table 196. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 207
Table 197. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 207
Table 198. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 208
Table 199. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 208
Table 200. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 208
Table 201. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 209
Table 202. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 209
Table 203. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 211
Table 204. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 211
Table 205. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 212
Table 206. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 212
Table 207. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 212
Table 208. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 213
Table 209. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 213
Table 210. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 215
Table 211. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 215
Table 212. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 216
Table 213. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 216
Table 214. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 216
Table 215. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 217
Table 216. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 217
Table 217. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 219
Table 218. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 220
Table 219. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 221
Table 220. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 222
Table 221. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 223
Table 222. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 224
Table 223. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 225
Table 224. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country. 226
Table 225. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 228
Table 226. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 228
Table 227. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 229
Table 228. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 229
Table 229. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 229
Table 230. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 230
Table 231. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 230
Table 232. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 232
Table 233. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 232
Table 234. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 233
Table 235. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 233
Table 236. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 233
Table 237. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 234
Table 238. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 234
Table 239. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type. 236
Table 240. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application. 236
Table 241. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source. 237
Table 242. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offering. 237
Table 243. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Instruments. 237
Table 244. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Consumables. 238
Table 245. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method. 238
Table 246. Recent Organic Growth Strategies in Organoids Market 240
Table 247. Recent Inorganic Growth Strategies in the Organoids Market 241
List of Figures
Figure 1. Organoids Market Segmentation, by Geography. 40
Figure 2. PEST Analysis. 45
Figure 3. Impact Analysis of Drivers and Restraints. 49
Figure 4. Organoids Market Revenue (US$ Million), 2021–2031. 50
Figure 5. Organoids Market Share (%) – by Type (2023 and 2031) 52
Figure 6. Intestine: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 53
Figure 7. Liver: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 54
Figure 8. Stomach: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 55
Figure 9. Pancreas: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 56
Figure 10. Lung: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 57
Figure 11. Brain: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 58
Figure 12. Kidney: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 59
Figure 13. Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 60
Figure 14. Organoids Market Share (%) – by Application (2023 and 2031) 61
Figure 15. Developmental Biology Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 62
Figure 16. Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 63
Figure 17. Regenerative Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 64
Figure 18. Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 65
Figure 19. Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 66
Figure 20. Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 67
Figure 21. Organoids Market Share (%) – by Source (2023 and 2031) 68
Figure 22. Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 69
Figure 23. Organ-Specific Adult Stem Cell: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 70
Figure 24. Organoids Market Share (%) – by Offering (2023 and 2031) 71
Figure 25. Instruments: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 72
Figure 26. Consumables: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 73
Figure 27. Services: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 74
Figure 28. Organoids Market Share (%) – by Method (2023 and 2031) 75
Figure 29. Micropatterned Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 76
Figure 30. Ultralow Attachment Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 77
Figure 31. Hanging Drop: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 78
Figure 32. Microdroplet or Emulsion: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 79
Figure 33. Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million) 80
Figure 34. Organoids Market Breakdown by Region, 2023 and 2031 (%) 81
Figure 35. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) 82
Figure 36. North America: Organoids Market Breakdown, by Type (2023 and 2031) 83
Figure 37. North America: Organoids Market Breakdown, by Application (2023 and 2031) 84
Figure 38. North America: Organoids Market Breakdown, by Source (2023 and 2031) 85
Figure 39. North America: Organoids Market Breakdown, by Offering (2023 and 2031) 86
Figure 40. North America: Organoids Market Breakdown, by Instruments (2023 and 2031) 87
Figure 41. North America: Organoids Market Breakdown, by Consumables (2023 and 2031) 88
Figure 42. North America: Organoids Market Breakdown, by Method (2023 and 2031) 89
Figure 43. North America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%) 90
Figure 44. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) 91
Figure 45. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) 95
Figure 46. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) 99
Figure 47. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) 103
Figure 48. Europe: Organoids Market Breakdown, by Type (2023 and 2031) 104
Figure 49. Europe: Organoids Market Breakdown, by Application (2023 and 2031) 105
Figure 50. Europe: Organoids Market Breakdown, by Source (2023 and 2031) 106
Figure 51. Europe: Organoids Market Breakdown, by Offering (2023 and 2031) 107
Figure 52. Europe: Organoids Market Breakdown, by Instruments (2023 and 2031) 108
Figure 53. Europe: Organoids Market Breakdown, by Consumables (2023 and 2031) 109
Figure 54. Europe: Organoids Market Breakdown, by Method (2023 and 2031) 110
Figure 55. Europe: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%) 111
Figure 56. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) 112
Figure 57. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) 116
Figure 58. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) 120
Figure 59. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) 124
Figure 60. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) 128
Figure 61. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) 132
Figure 62. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) 136
Figure 63. Asia Pacific: Organoids Market Breakdown, by Type (2023 and 2031) 137
Figure 64. Asia Pacific: Organoids Market Breakdown, by Application (2023 and 2031) 138
Figure 65. Asia Pacific: Organoids Market Breakdown, by Source (2023 and 2031) 139
Figure 66. Asia Pacific: Organoids Market Breakdown, by Offering (2023 and 2031) 140
Figure 67. Asia Pacific: Organoids Market Breakdown, by Instruments (2023 and 2031) 141
Figure 68. Asia Pacific: Organoids Market Breakdown, by Consumables (2023 and 2031) 142
Figure 69. Asia Pacific: Organoids Market Breakdown, by Method (2023 and 2031) 143
Figure 70. Asia Pacific: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%) 144
Figure 71. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) 145
Figure 72. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) 149
Figure 73. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) 153
Figure 74. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) 157
Figure 75. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) 161
Figure 76. Singapore: Organoids Market – Revenue and Forecast to 2031(US$ Million) 165
Figure 77. Thailand: Organoids Market – Revenue and Forecast to 2031(US$ Million) 169
Figure 78. Malaysia: Organoids Market – Revenue and Forecast to 2031(US$ Million) 173
Figure 79. Vietnam: Organoids Market – Revenue and Forecast to 2031(US$ Million) 177
Figure 80. Indonesia: Organoids Market – Revenue and Forecast to 2031(US$ Million) 181
Figure 81. Philippines: Organoids Market – Revenue and Forecast to 2031(US$ Million) 185
Figure 82. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) 189
Figure 83. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) 193
Figure 84. Middle East and Africa: Organoids Market Breakdown, by Type (2023 and 2031) 194
Figure 85. Middle East and Africa: Organoids Market Breakdown, by Application (2023 and 2031) 195
Figure 86. Middle East and Africa: Organoids Market Breakdown, by Source (2023 and 2031) 196
Figure 87. Middle East and Africa: Organoids Market Breakdown, by Offering (2023 and 2031) 197
Figure 88. Middle East and Africa: Organoids Market Breakdown, by Instruments (2023 and 2031) 198
Figure 89. Middle East and Africa: Organoids Market Breakdown, by Consumables (2023 and 2031) 199
Figure 90. Middle East and Africa: Organoids Market Breakdown, by Method (2023 and 2031) 200
Figure 91. Middle East and Africa: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%) 201
Figure 92. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) 202
Figure 93. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) 206
Figure 94. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) 210
Figure 95. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) 214
Figure 96. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) 218
Figure 97. South and Central America: Organoids Market Breakdown, by Type (2023 and 2031) 219
Figure 98. South and Central America: Organoids Market Breakdown, by Application (2023 and 2031) 220
Figure 99. South and Central America: Organoids Market Breakdown, by Source (2023 and 2031) 221
Figure 100. South and Central America: Organoids Market Breakdown, by Offering (2023 and 2031) 222
Figure 101. South and Central America: Organoids Market Breakdown, by Instruments (2023 and 2031) 223
Figure 102. South and Central America: Organoids Market Breakdown, by Consumables (2023 and 2031) 224
Figure 103. South and Central America: Organoids Market Breakdown, by Method (2023 and 2031) 225
Figure 104. South and Central America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%) 226
Figure 105. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) 227
Figure 106. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) 231
Figure 107. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) 235
Figure 108. Growth Strategies in Organoids Market 239
The List of Companies - Organoids Services Market
- Sino Biological Inc.
- Eurofins Scientific SE
- Molecular Devices, LLC.
- InSphero;
- Cyprio
- InnoSer
- LABTOO
- CUSABIO TECHNOLOGY LLC
- Oncodesign Services
- HUB Organoids B.V. (Hubrecht Organoid Technology)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For